Physician profile
Amy E Massa
NPI 1760739668
$507.11
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.24 · 2023: $87.19 · 2024: $211 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.02 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $150.81 | 2023-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $83.59 | 2023-2025 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.17 | 2023-2025 | Jardiance, Tradjenta |
| Exact Sciences Corporation | $36.18 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $35.09 | 2024-2025 | Breztri |
| Insulet Corporation | $27.46 | 2025 | Omnipod |
| Amgen INC. | $24.80 | 2021-2024 | Repatha, Otezla |
| Abbott Laboratories | $23.37 | 2024 | Freestyle Libre 3 |
| Sunovion Pharmaceuticals INC. | $18.20 | 2021 | |
| Dexcom, INC. | $17.05 | 2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $13.39 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Massa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.